Article : Article de périodique

Use of etonogestrel implant beyond approved duration : prolonged contraceptive effectiveness

B.C. RIBEIRO, Auteur ; C. NOGUEIRA-SILVA, Auteur ; H. AFONSO, Auteur |

Dans EUROPEAN JOURNAL OF CONTRACEPTION & REPRODUCTIVE HEALTH CARE (THE) (Vol. 23 - N° 4, August 2018)

The subdermal etonogestrel contraceptive implant has a current approved duration of 3 years. There is, however, recent and strong evidence of its effectiveness for 2 additional years during which no pregnancies were documented.

Plus d'information...

Ajouter au panier

Non prêtable